Margit Wissenbach

Person

Fredensborg, DK

People

Patents Grantslast 30 patents

Information Patent Grant
LNA oligonucleotides and the treatment of cancer
- Patent number 8,173,428
- Issue date May 8, 2012
- Santaris Pharma A/S
- Christoph Rosenbohm
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Oligomeric compounds for the modulation of survivin expression
- Patent number 8,026,355
- Issue date Sep 27, 2011
- Santaris Pharma A/S
- Jens Bo Rode Hansen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Oligomeric compounds for the modulation of survivin expression
- Patent number 7,741,309
- Issue date Jun 22, 2010
- Enzon Pharmaceuticals
- Jens Bo Rode Hansen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Oligomeric compounds for the modulation of survivin expression
- Patent number 7,713,738
- Issue date May 11, 2010
- Enzon Pharmaceuticals, Inc.
- Bo Hansen
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
LNA OLIGONUCLEOTIDES AND THE TREATMENT OF CANCER
- Publication number 20120322848
- Publication date Dec 20, 2012
- Santaris Pharma A/S
- Christoph Rosenbohm
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
OLIGOMERIC COMPOUNDS FOR THE MODULATION OF SURVIVIN EXPRESSION
- Publication number 20120088907
- Publication date Apr 12, 2012
- Santaris Pharma A/S
- Bo Hansen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
OLIGOMERIC COMPOUNDS FOR THE MODULATION OF SURVIVIN EXPRESSION
- Publication number 20100292311
- Publication date Nov 18, 2010
- Enzon Pharmaceuticals
- Bo Hansen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
OLIGOMERIC COMPOUNDS FOR THE MODULATION OF SURVIVIN EXPRESSION
- Publication number 20090318362
- Publication date Dec 24, 2009
- Jens Bo rode Hansen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
LNA OLIGONUCLEOTIDES AND THE TREATMENT OF CANCER
- Publication number 20090181914
- Publication date Jul 16, 2009
- Santaris Pharma A/S
- CHRISTOPH ROSENBOHM
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Oligomeric compounds for the modulation ras expression
- Publication number 20080188432
- Publication date Aug 7, 2008
- Bo Hansen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
LNA oligonucleotides and the treatment of cancer
- Publication number 20060154888
- Publication date Jul 13, 2006
- Santaris Pharma A/S
- Christoph Rosenbohm
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Oligomeric compounds for the modulation survivin expression
- Publication number 20050014712
- Publication date Jan 20, 2005
- Bo Hansen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Oligomeric compounds for the modulation of ras expression
- Publication number 20040248840
- Publication date Dec 9, 2004
- Santaris Pharma A/S
- Bo Hansen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Oligomeric compounds for the modulation of thioredoxin expression
- Publication number 20040241717
- Publication date Dec 2, 2004
- Santaris Pharma A/S
- Bo Hansen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Therapeutic uses of LNA-modified oligonucleotides in infectious dis...
- Publication number 20030125241
- Publication date Jul 3, 2003
- Margit Wissenbach
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Margit Wissenbach

Person

Patents Grantslast 30 patents

LNA oligonucleotides and the treatment of cancer

Oligomeric compounds for the modulation of survivin expression

Oligomeric compounds for the modulation of survivin expression

Oligomeric compounds for the modulation of survivin expression

Patents Applicationslast 30 patents

LNA OLIGONUCLEOTIDES AND THE TREATMENT OF CANCER

OLIGOMERIC COMPOUNDS FOR THE MODULATION OF SURVIVIN EXPRESSION

OLIGOMERIC COMPOUNDS FOR THE MODULATION OF SURVIVIN EXPRESSION

OLIGOMERIC COMPOUNDS FOR THE MODULATION OF SURVIVIN EXPRESSION

LNA OLIGONUCLEOTIDES AND THE TREATMENT OF CANCER

Oligomeric compounds for the modulation ras expression

LNA oligonucleotides and the treatment of cancer

Oligomeric compounds for the modulation survivin expression

Oligomeric compounds for the modulation of ras expression

Oligomeric compounds for the modulation of thioredoxin expression

Therapeutic uses of LNA-modified oligonucleotides in infectious dis...